1-3 of 3
STephen J. Proctor, MD
Close
Sort by
Journal Articles

Mature MicroRNAs Mir-18, -19a, -19b, -17-5p and -92 of the Mir-17-92 Cluster Predict for Treatment Free Survival In Patients with Chronic Lymphocytic Leukaemia

Rachel E. Culpin, BSc, (Hons), Kim Pearce, PhD, James R. Bailey, MD, PhD, Nicola J. Sunter, PhD, Joanna C. Pointon, PhD, Stephen J. Proctor, MD, David J. Allsup, PhD, MRCP, FRCPath, James M. Allan, PhD, Tryfonia Mainou-Fowler, PhD
Journal: Blood
Blood (2010) 116 (21): 2727.
https://doi.org/10.1182/blood.V116.21.2727.2727
Published: 2010
Journal Articles

SGN-30 (Anti-CD30 mAb) Has a Single-Agent Response Rate of 21% in Patients with Refractory or Recurrent Systemic Anaplastic Large Cell Lymphoma (ALCL).

Andres Forero-Torres, MD, STeven H. Bernstein, MD, Ajay Gopal, MD, Francine Foss, MD, John P. Leonard, MD, Joseph D. Rosenblatt, MD, Nancy L. Bartlett, MD, Bruce D. Cheson, MD, Elliot Epner, MD, Francisco J. Hernandez-Ilizaliturri, MD, STephen J. Proctor, MD, Pauline Brice, MD, Herve Tilly, MD, Corinne Haioun, MD, Mats Jerkeman, MD, Andre Bosly, MD, Alessandro M. Gianni, MD, Harald Holte, MD, Premini Mahendra, MD, Lutz Uharek, MD, Jennie Lorenz, Jeremy Barton, MD, Eric Sievers, MD
Journal: Blood
Blood (2006) 108 (11): 2718.
https://doi.org/10.1182/blood.V108.11.2718.2718
Published: 2006
Journal Articles

SGN-30 (Anti-CD30 Monoclonal Antibody) Is Active and Well Tolerated in Patients with Refractory or Recurrent Systemic Anaplastic Large Cell Lymphoma (ALCL).

Andres Forero-Torres, MD, Steven H. Bernstein, MD, Ajay K. Gopal, MD, Francine Foss, MD, John P. Leonard, MD, Joseph D. Rosenblatt, MD, Nancy L. Bartlett, MD, Bruce D. Cheson, MD, Elliott Epner, MD, Francisco J. Hernandez-Illizaliturri, MD, Stephen J. Proctor, MD, Pauline Brice, MD, Harve Tilly, MD, Corinne Haioun, MD, Mats Jerkeman, MD, Andre Bosly, MD, Jennie M. Lorenz, Jeremy Barton, MD
Journal: Blood
Blood (2005) 106 (11): 3356.
https://doi.org/10.1182/blood.V106.11.3356.3356
Published: 2005